한미약품 2세 임종훈 개인회사 상법위반 논란… 사내이사직 '흔들'

Hanmi Pharmaceutical's second-generation executive is under scrutiny for potential violations of commercial law by establishing and operating private investment companies while maintaining an insider director position at the company. This case highlights critical governance failures and raises concerns about management transparency, as the company was reportedly unaware of these conflicting business operations. The situation underscores the importance of board oversight and strict adherence to fiduciary duties in family-controlled conglomerates.